Release Date: 31/01/24 18:17 Summary: Final Distribution Announcement Price Sensitive: Yes Download Document 197.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%